Justin D. Floyd

2.1k total citations
17 papers, 846 citations indexed

About

Justin D. Floyd is a scholar working on Oncology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Justin D. Floyd has authored 17 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Dermatology. Recurrent topics in Justin D. Floyd's work include Peptidase Inhibition and Analysis (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chemotherapy-related skin toxicity (3 papers). Justin D. Floyd is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chemotherapy-related skin toxicity (3 papers). Justin D. Floyd collaborates with scholars based in United States, Malaysia and Italy. Justin D. Floyd's co-authors include Michael C. Perry, Irfan Ali Mirza, Donald C. Doll, Duc T. Nguyen, Qaiser Bashir, Carol J. Fabian, Erin Hofstatter, Judy E. Garber, Carolyn D. Runowicz and Mark R. Somerfield and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Justin D. Floyd

17 papers receiving 819 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Justin D. Floyd	475	207	178	121	121	17	846
Gülten Tekuzman	334 0.7×	234 1.1×	171 1.0×	111 0.9×	143 1.2×	58	737
Pooja Advani	358 0.8×	116 0.6×	107 0.6×	219 1.8×	100 0.8×	67	799
Marcella Occelli	353 0.7×	226 1.1×	176 1.0×	141 1.2×	46 0.4×	29	691
Alessandro Inno	695 1.5×	144 0.7×	329 1.8×	258 2.1×	154 1.3×	80	1.2k
Khaled El‐Shami	391 0.8×	128 0.6×	122 0.7×	208 1.7×	58 0.5×	22	913
Anna Fedeli	536 1.1×	73 0.4×	369 2.1×	108 0.9×	58 0.5×	43	939
Nadia Yousaf	619 1.3×	229 1.1×	400 2.2×	182 1.5×	41 0.3×	48	1.2k
Akke Botma	391 0.8×	365 1.8×	199 1.1×	96 0.8×	234 1.9×	20	958
Emanuele Naglieri	336 0.7×	107 0.5×	200 1.1×	210 1.7×	77 0.6×	42	1.0k
Javier Gómez	361 0.8×	180 0.9×	373 2.1×	270 2.2×	86 0.7×	51	1.0k

Countries citing papers authored by Justin D. Floyd

Since Specialization

Citations

This map shows the geographic impact of Justin D. Floyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin D. Floyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin D. Floyd more than expected).

Fields of papers citing papers by Justin D. Floyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin D. Floyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin D. Floyd. The network helps show where Justin D. Floyd may publish in the future.

Co-authorship network of co-authors of Justin D. Floyd

This figure shows the co-authorship network connecting the top 25 collaborators of Justin D. Floyd. A scholar is included among the top collaborators of Justin D. Floyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin D. Floyd. Justin D. Floyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wong, Siu‐Fun, Joseph M. Unger, James L. Wade, et al.. (2020). A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. Journal of Patient-Reported Outcomes. 4(1). 3 indexed citations

Poznak, Catherine Van, Joseph M. Unger, Amy K. Darke, et al.. (2020). Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. JAMA Oncology. 7(2). 246–246. 49 indexed citations

Visvanathan, Kala, Carol J. Fabian, Elissa Bantug, et al.. (2019). Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology. 37(33). 3152–3165. 117 indexed citations

Minasian, Lori M., Eileen Dimond, Bishow B. Adhikari, et al.. (2019). The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity. JACC CardioOncology. 1(1). 105–113. 14 indexed citations

Poznak, Catherine Van, Joseph M. Unger, Amy K. Darke, et al.. (2019). Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211.. Journal of Clinical Oncology. 37(15_suppl). 11502–11502. 6 indexed citations

Barr, Paul M., Hongli Li, Richard Burack, et al.. (2018). R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study. The Lancet Haematology. 5(3). e102–e108. 14 indexed citations

Pham, Chau, et al.. (2017). Acute Angle Closure Precipitated by Hemorrhage and Necrosis of a Large Uveal Melanoma in the Setting of Systemic Immunomodulatory Therapy. Ocular Oncology and Pathology. 3(4). 254–258. 1 indexed citations

Till, Brian G., Hongli Li, Steven H. Bernstein, et al.. (2015). PhaseIItrial of R‐CHOPplus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma:SWOGS0601. British Journal of Haematology. 172(2). 208–218. 33 indexed citations

Till, Brian G., Hongli Li, Steven H. Bernstein, et al.. (2014). Phase II Trial of R-CHOP Plus Bortezomib Induction Therapy Followed By Bortezomib Maintenance for Previously Untreated Mantle Cell Lymphoma: SWOG 0601. Blood. 124(21). 149–149. 10 indexed citations

10.

Naam, Nash H., et al.. (2013). Multicentric Giant Cell Tumor of the Fourth and Fifth Metacarpals with Lung Metastases. Hand. 9(3). 389–392. 15 indexed citations

11.

Gitlitz, Barbara J., James Moon, Bonnie S. Glisson, et al.. (2010). Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial. Journal of Thoracic Oncology. 5(11). 1835–1840. 49 indexed citations

12.

Floyd, Justin D., et al.. (2007). Small Cell Carcinoma of Unknown Primary. Seminars in Oncology. 34(1). 39–42. 22 indexed citations

13.

Floyd, Justin D., et al.. (2006). Hepatotoxicity of Chemotherapy. Seminars in Oncology. 33(1). 50–67. 182 indexed citations

14.

Floyd, Justin D., et al.. (2006). Pulmonary Toxicity of Chemotherapy. Seminars in Oncology. 33(1). 98–105. 54 indexed citations

15.

Floyd, Justin D., et al.. (2005). Cardiotoxicity of Cancer Therapy. Journal of Clinical Oncology. 23(30). 7685–7696. 268 indexed citations

16.

Floyd, Justin D., et al.. (2005). Patients With Unusual Bladder Malignancies and a Rare Cause of Splenomegaly. Journal of Clinical Oncology. 23(19). 4460–4462. 3 indexed citations

17.

Spanier, Suzanne S. & Justin D. Floyd. (1989). A clinicopathologic comparison of malignant fibrous histiocytoma and liposarcoma.. PubMed. 38. 407–17. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact